Mark Yamanaka
15Patents
7h-index
33Co-inventors
62Inventor score
Filing activity: Nov 30, 2007 → Dec 7, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10344089B2 | Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof | Chemistry; Metallurgy | 20 | Active |
| US8481683B2 | Human antibodies that bind CD22 and uses thereof | Chemistry; Metallurgy | 9 | Active |
| US10988535B2 | Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof | Chemistry; Metallurgy | 9 | Active |
| US10988536B2 | Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof | Chemistry; Metallurgy | 9 | Active |
| US8680247B2 | Monoclonal antibodies against glypican-3 | Chemistry; Metallurgy | 9 | Active |
| US11001630B2 | Human antibodies that bind lymphocyte activation Gene-3 (LAG-3), and uses thereof | Chemistry; Metallurgy | 9 | Active |
| US9499632B2 | Human antibodies that bind CD22 and uses thereof | Chemistry; Metallurgy | 7 | Active |
| US11236164B2 | Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US11236163B2 | Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US11236165B2 | Human antibodies that bind Lymphocyte Activation Gene-3 (LAG-3), and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US8039596B2 | Alpha 5-beta 1 antibodies and their uses | Chemistry; Metallurgy | 3 | Active |
| US11530267B2 | Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US11512130B2 | Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US8399647B2 | Alpha5-beta1 antibodies and their uses | Chemistry; Metallurgy | 0 | Active |
| US9217033B2 | Monoclonal antibodies against Glypican-3 | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.